Innovation in Compliance: Earlier Initiation of Long-Acting Injectables to Avoid Relapse & Improve Patient Outcomes
Time: 12:00 pm
day: Day One
Details:
- Leveraging long-acting injectables (LAIs) as an early intervention to address non-compliance in psychosis treatment, advanced delivery systems, and patient-centric solutions
- Highlighting the benefits of early LAI initiation, improved side-effect profiles
- To reduce relapses, prevent chronicity, and improve treatment outcomes by minimizing the biological and psychological impacts of non-compliance, fostering better patient experiences, and advancing long-term recovery
